» Articles » PMID: 29849877

Biological Activities and Potential Oral Applications of N-Acetylcysteine: Progress and Prospects

Overview
Publisher Wiley
Date 2018 Jun 1
PMID 29849877
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

N-Acetylcysteine (NAC), a cysteine prodrug and glutathione (GSH) precursor, has been used for several decades in clinical therapeutic practices as a mucolytic agent and for the treatment of disorders associated with GSH deficiency. Other therapeutic activities of NAC include inhibition of inflammation/NF-B signaling and expression of proinflammatory cytokines. N-Acetylcysteine is also a nonantibiotic compound possessing antimicrobial property and exerts anticarcinogenic and antimutagenic effects against certain types of cancer. Recently, studies describing potentially important biological and pharmacological activities of NAC have stimulated interests in using NAC-based therapeutics for oral health care. The present review focused on the biological activities of NAC and its potential oral applications. The potential side effects of NAC and formulations for drug delivery were also discussed, with the intent of advancing NAC-associated treatment modalities in oral medicine.

Citing Articles

Effect of N-acetylcysteine on antimicrobials induced nephrotoxicity: a meta-analysis.

Qiu X, Yang S, Zhang Y, Wang Q, Kong L, Zhou L BMC Nephrol. 2025; 26(1):128.

PMID: 40057704 PMC: 11890532. DOI: 10.1186/s12882-025-04037-y.


Disruption of tryptophan metabolism by high-fat diet-triggered maternal immune activation promotes social behavioral deficits in male mice.

Sun P, Wang M, Chai X, Liu Y, Li L, Zheng W Nat Commun. 2025; 16(1):2105.

PMID: 40025041 PMC: 11873046. DOI: 10.1038/s41467-025-57414-4.


Antimicrobial and Antibiofilm Activity of Auranofin and Its Two Derivatives Bearing Naproxen and Acetylcysteine as Ligands Against Staphylococci.

Ferretti C, Chiaverini L, Poma N, Dalli A, Di Leo R, Rindi L Antibiotics (Basel). 2025; 14(2).

PMID: 40001362 PMC: 11851661. DOI: 10.3390/antibiotics14020118.


deficiency in mouse oocytes during in vitro maturation increases chromosome segregation errors with a reduced BUBR1 at kinetochore.

Nago M, Yanai M, Ishii M, Sato Y, Odajima K, Kimura N Reprod Med Biol. 2025; 24(1):e12622.

PMID: 39845481 PMC: 11751902. DOI: 10.1002/rmb2.12622.


The potential role of N-acetylcysteine as an adjuvant therapy in acute aluminum phosphide poisoning: a randomized clinical trial.

Abd El-Khalek S, Amin S, El-Ebiary A, Elfeky A, Kandeel F Toxicol Res (Camb). 2025; 14(1):tfae210.

PMID: 39830885 PMC: 11741682. DOI: 10.1093/toxres/tfae210.


References
1.
Kamata H, Shibukawa Y, Oka S, Hirata H . Epidermal growth factor receptor is modulated by redox through multiple mechanisms. Effects of reductants and H2O2. Eur J Biochem. 2000; 267(7):1933-44. DOI: 10.1046/j.1432-1327.2000.01194.x. View

2.
Atkuri K, Mantovani J, Herzenberg L, Herzenberg L . N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007; 7(4):355-9. PMC: 4540061. DOI: 10.1016/j.coph.2007.04.005. View

3.
Benrahmoune M, Therond P, Abedinzadeh Z . The reaction of superoxide radical with N-acetylcysteine. Free Radic Biol Med. 2000; 29(8):775-82. DOI: 10.1016/s0891-5849(00)00380-4. View

4.
DE Flora S, Bennicelli C, Zanacchi P, Camoirano A, Morelli A, De Flora A . In vitro effects of N-acetylcysteine on the mutagenicity of direct-acting compounds and procarcinogens. Carcinogenesis. 1984; 5(4):505-10. DOI: 10.1093/carcin/5.4.505. View

5.
Yoshida A, Shiotsu-Ogura Y, Wada-Takahashi S, Takahashi S, Toyama T, Yoshino F . Blue light irradiation-induced oxidative stress in vivo via ROS generation in rat gingival tissue. J Photochem Photobiol B. 2015; 151:48-53. DOI: 10.1016/j.jphotobiol.2015.07.001. View